{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:20:53Z","timestamp":1787163653038,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.contraception.2015.12.014","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T13:16:20Z","timestamp":1451913380000},"page":"367-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["One year quality of life measured with SEC-QoL in levonorgestrel 52 mg IUS users"],"prefix":"10.1016","volume":"93","author":[{"given":"Ignacio","family":"Cristobal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ignacio","family":"Lete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther de la","family":"Viuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Perulero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-6079","authenticated-orcid":false,"given":"Agnes","family":"Arbat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Canals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2015.12.014_bb0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpag.2014.02.015","article-title":"Factors associated with contraceptive satisfaction in adolescent women using the IUD","volume":"28","author":"Friedman","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.contraception.2015.12.014_bb0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0039-128X(00)00176-8","article-title":"The levonorgestrel intrauterine system in contraception","volume":"65","author":"L\u00e4hteenm\u00e4ki","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2015.12.014_bb0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.12.014_bb0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajog.2007.10.787","article-title":"Contraceptive efficacy of intrauterine devices","volume":"198","author":"Thonneau","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.12.014_bb0025","first-page":"561","article-title":"The levonorgestrel-releasing intrauterine system: safety, efficacy, and patient acceptability","volume":"5","author":"Beatty","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.contraception.2015.12.014_bb0030","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/PPA.S45710","article-title":"Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States","volume":"8","author":"Yoost","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.contraception.2015.12.014_bb0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.whi.2008.07.002","article-title":"Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment","volume":"19","author":"Frick","year":"2009","journal-title":"Womens Health Issues"},{"key":"10.1016\/j.contraception.2015.12.014_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/aogs.12287","article-title":"Reduced quality of life when experiencing menstrual pain in women with primary dysmenorrhea","volume":"93","author":"Iacovides","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2015.12.014_bb0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/aogs.12292","article-title":"Heavy menstrual bleeding significantly affects quality of life","volume":"93","author":"Karlsson","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2015.12.014_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2007.01586.x","article-title":"Review of quality of life: menorrhagia in women with or without inherited bleeding disorders","volume":"14","author":"Shankar","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.contraception.2015.12.014_bb0055","author":"National Institute for Health and Clinical Excellence (NICE)"},{"key":"10.1016\/j.contraception.2015.12.014_bb0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2015.12.014_bb0065","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/ajo.12097","article-title":"Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding: a 6- and 12-month morphological and clinical follow-up","volume":"53","author":"Palmara","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2015.12.014_bb0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2011.01.020","article-title":"Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center","volume":"84","author":"Bastianelli","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.12.014_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1479-828X.2004.00206.x","article-title":"Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire","volume":"44","author":"Radesic","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2015.12.014_bb0080","first-page":"1059","article-title":"Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system - mirena","volume":"32","author":"Skrzypulec","year":"2008","journal-title":"Coll Antropol"},{"key":"10.1016\/j.contraception.2015.12.014_bb0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/13625180802075075","article-title":"Spanish society of gynaecology obstetrics (SEGO). the levonorgestrel intrauterine system (mirena) for treatment of idiopathic menorrhagia. Assessment of quality of life and satisfaction","volume":"13","author":"Lete","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2015.12.014_bb0090","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jval.2011.08.1729","article-title":"Development and validation of the SEC-QoL quality of life questionnaire in women using contraceptive methods","volume":"14","author":"P\u00e9rez-Campos","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.contraception.2015.12.014_bb0095","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/humrep\/det101","article-title":"The influence of intrauterine contraception on the prevalence and severity of dysmenorrheal: a longitudinal population study","volume":"28","author":"Lindh","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2015.12.014_bb0100","first-page":"74","article-title":"The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review","volume":"108","author":"Stewart","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2015.12.014_bb0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/11598960-000000000-00000","article-title":"The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit\u2013risk review","volume":"72","author":"Kaunitz","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2015.12.014_bb0110","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.12659\/MSM.892126","article-title":"Levonorgestrel-releasing intrauterine system versus medical therapy for menorrhagia: a systematic review and meta-analysis","volume":"20","author":"Qiu","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.contraception.2015.12.014_bb0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000320336","article-title":"Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin","volume":"71","author":"Zakherah","year":"2011","journal-title":"Gynecol Obstet Investig"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415300512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415300512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T11:50:14Z","timestamp":1718279414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782415300512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0010782415300512"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2015.12.014","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One year quality of life measured with SEC-QoL in levonorgestrel 52mg IUS users","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2015.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}